Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 58,982,285
- Share change
- -1,282,528
- Total reported value
- $608,669,781
- Put/Call ratio
- 414%
- Price per share
- $10.32
- Number of holders
- 147
- Value change
- -$13,934,484
- Number of buys
- 71
- Number of sells
- 89
Report period
Q2 2021
Institutions
147
Top holders
10
KPTI full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
34%
|
7,749,757
|
$81,528,000 | — | 31 Mar 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
24%
|
5,363,652
|
$56,426,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
24%
|
5,332,280
|
$56,096,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
3,556,453
|
$37,414,000 | — | 31 Mar 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
12%
|
2,668,199
|
$28,070,000 | — | 31 Mar 2021 | |
| Delphi Management Partners VIII, L.L.C. |
13F
|
Company |
10%
|
2,263,006
|
$23,806,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.5%
|
1,917,768
|
$20,174,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
7.5%
|
1,698,473
|
$17,868,000 | — | 31 Mar 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
6.9%
|
1,563,044
|
$16,443,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
6.6%
|
1,492,642
|
$15,703,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6%
|
1,349,800
|
$14,200,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
5.9%
|
1,331,104
|
$14,003,000 | — | 31 Mar 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
5.4%
|
1,221,627
|
$12,852,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
5.3%
|
1,211,971
|
$12,750,000 | — | 31 Mar 2021 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
5.3%
|
1,200,000
|
$12,624,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
1,146,715
|
$12,063,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
4.3%
|
980,464
|
$10,314,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
4.2%
|
951,530
|
$14,149,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
4.1%
|
929,561
|
$9,779,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4%
|
910,200
|
$9,575,000 | — | 31 Mar 2021 | |
| Hood River Capital Management LLC |
13F
|
Company |
3.7%
|
848,707
|
$8,928,000 | — | 31 Mar 2021 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
3.7%
|
829,681
|
$8,728,000 | — | 31 Mar 2021 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
3.7%
|
829,681
|
$8,728,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.6%
|
822,516
|
$8,652,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.3%
|
745,036
|
$7,837,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.3%
|
739,714
|
$7,782,000 | — | 31 Mar 2021 | |
| Granahan Investment Management, LLC |
13F
|
Company |
3%
|
690,410
|
$7,263,000 | — | 31 Mar 2021 | |
| AMI ASSET MANAGEMENT CORP |
13F
|
Company |
2.2%
|
501,172
|
$5,272,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
492,955
|
$5,186,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2%
|
452,244
|
$4,758,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
381,059
|
$4,009,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
339,747
|
$3,575,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
1.5%
|
336,046
|
$3,535,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
319,758
|
$3,365,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
305,458
|
$3,213,000 | — | 31 Mar 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.3%
|
291,187
|
$3,063,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
288,553
|
$3,035,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
1.2%
|
274,374
|
$2,887,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
1.2%
|
270,663
|
$2,847,000 | — | 31 Mar 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
1.2%
|
266,968
|
$2,809,000 | — | 31 Mar 2021 | |
| Birchview Capital, LP |
13F
|
Company |
1%
|
230,000
|
$2,420,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
225,280
|
$2,370,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.79%
|
178,704
|
$1,880,000 | — | 31 Mar 2021 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.78%
|
175,789
|
$1,849,000 | — | 31 Mar 2021 | |
| Junson Asset Management (Hong Kong) Ltd |
13F
|
Company |
0.66%
|
150,000
|
$1,571,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.65%
|
146,603
|
$1,542,000 | — | 31 Mar 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.65%
|
146,442
|
$1,541,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.64%
|
146,021
|
$1,537,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.63%
|
143,000
|
$1,504,000 | — | 31 Mar 2021 | |
| Phocas Financial Corp. |
13F
|
Company |
0.6%
|
135,816
|
$1,429,000 | — | 31 Mar 2021 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q2 2021
As of 30 Jun 2021,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,982,285 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Palo Alto Investors LP, Rubric Capital Management LP, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, Delphi Management Partners VIII, L.L.C., MORGAN STANLEY, FRONTIER CAPITAL MANAGEMENT CO LLC, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
147
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
163
Q2 2021 holders
147
Holder diff
-16
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.